A Chinese newspaper reported today that the eye care division had paid doctors in more than 200 hospitals for phony clinical trials.
Dumex, the baby food brand owned by France’s Danone, said on Monday it was investigating allegations on Chinese state television that the company bribed doctors and nurses to recommend its infant formula to the parents of newborns at some hospitals.
China has launched a high-profile campaign against purported corruption among foreign pharmaceutical companies this summer. UPDATED
After revealing a review of sex bribery allegations in China earlier this year, Agilent now says it is investigating the use of third-party agents in that country.
Expanding the investigation to include the China allegations is a routine step.
U.K. laws could prevent it from pursuing a case against one of its own companies if Chinese and U.S. authorities have gotten there first.
U.S. drugmaker Eli Lilly and Co said it was “deeply concerned” about allegations published in a Chinese newspaper that it spent more than 30 million yuan ($4.90 million) to bribe doctors in China to prescribe the firm’s medicines instead of rival products.
The U.S. has taken the lead on investigating the mining concern, with Australian authorities embarrassed into taking belated action.
Chinese authorities have recently brought intense pressure to bear on foreign drug makers over alleged bribery.
Company directors won plaudits for the acquisition of a Chinese drug maker in 2011 but the outcome has been less rosy than it may originally have seemed.
At the moment, then, there are (at least) four investigations by Chinese authorities into foreign companies: Baxter, Sanofi, GSK and AstraZeneca.
A low-ball initial offer is rejected and Avon says it expects to pay more for alleged bribes in China and other countries. (Subscription required)
Just Anti-Corruption reported the disclosure as it occurred last year. Other media suggested the disclosure was made this week.
The judge refused to approve the deal for two years without the company agreeing to file reports to both him and the SEC on any potential violation.
If GSK isn’t the only pharmaceutical company under investigation by Chinese authorities, a look to the list of drug makers whose conduct in China has also been probed by the United States may offer clues to the others.
President Barack Obama speaks at outgoing Attorney General Eric Holder's portrait unveiling ceremony.
Attorney General Eric Holder called for a lower bar to federal civil rights prosecutions in an exit interview with Politico's Mike Allen.